Neurotech Startup Neurovalens Receives FDA Clearance for Noninvasive Anxiety Treatment

Neurovalens, a Belfast-based startup specializing in noninvasive electrical stimulation of the brain and nervous system, has achieved a significant milestone with the FDA clearance of its second head-mounted treatment device. This approval follows its first FDA clearance for a device targeting insomnia, with the latest approval focusing on treating generalized anxiety disorder (GAD). The company aims to address chronic conditions like obesity-related cardiometabolic risk and PTSD in the future. Devamını Oku

US Set to Award TSMC $6.6B in Grants, $5B in Loans to Ramp Up Chip Manufacturing in Arizona

The U.S. Commerce Department announced on Monday that it has inked a deal to allocate $6.6 billion in direct funding to Taiwan Semiconductor Manufacturing (TSMC) under the CHIPS and Science Act. This funding is designated for setting up semiconductor factories in Phoenix, Arizona, with an additional provision of up to $5 billion in loans. Devamını Oku

Vista Equity Partners to Privatize Revenue Optimization Platform Model N in $1.25B Deal

Model N, a platform utilized by major companies like Johnson & Johnson, AstraZeneca, and AMD to automate pricing, incentives, and compliance decisions, is transitioning to private ownership in a $1.25 billion deal with private equity firm Vista Equity Partners. This move highlights the trend of private equity firms acquiring tech companies that have faced challenges in public markets over the past few years. Devamını Oku